According to Natera's latest financial reports the company's current EPS (TTM) is -$4.82. In 2022 the company made an earnings per share (EPS) of -$5.57 a decrease over its 2021 EPS that were of -$5.18.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.82 | -13.46% |
2022 | -$5.57 | 7.53% |
2021 | -$5.18 | 83.04% |
2020 | -$2.83 | 56.35% |
2019 | -$1.81 | -18.83% |
2018 | -$2.23 | -12.55% |
2017 | -$2.55 | 30.77% |
2016 | -$1.95 | 29.1% |
2015 | -$1.51 | 536.64% |
2014 | -$0.24 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Vertex Pharmaceuticals VRTX | $13.09 | -371.58% | ๐บ๐ธ USA |
Prothena PRTA | -$2.76 | -42.74% | ๐ฎ๐ช Ireland |
Paratek Pharmaceuticals
PRTK | -$1.10 | -77.18% | ๐บ๐ธ USA |